During the past decade, Canberra Hospital; Haematology Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Canberra Hospital; Haematology Department" are "Chronic Lymphocytic Leukemia (CLL)" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Canberra Hospital; Haematology Department" in a lesser frequency.

Most popular intervention types in "Canberra Hospital; Haematology Department" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (1 trials), "Cyclophosphamide" (1 trials), "Cytarabine" (1 trials), "Fludarabine" (1 trials) and "Idasanutlin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Canberra Hospital; Haematology Department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Canberra Hospital; Haematology Department". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Canberra Hospital; Haematology Department, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Canberra Hospital; Haematology Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".